Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies
- 1 March 2015
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 69, 51-60
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasisJournal of Antimicrobial Chemotherapy, 2012
- Preparation and antitumor study of camptothecin nanocrystalsInternational Journal of Pharmaceutics, 2011
- Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of PaclitaxelAAPS PharmSciTech, 2011
- Optimization of formulation and process variable of nanosuspension: An industrial perspectiveInternational Journal of Pharmaceutics, 2010
- Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactivesExpert Opinion on Drug Delivery, 2010
- Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in CancerMolecular Pharmaceutics, 2010
- P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 2010
- Absorption Barriers in the Rat Intestinal Mucosa. 3: Effects of Polyethoxylated Solubilizing Agents on Drug Permeation and MetabolismJournal of Pharmaceutical Sciences, 2010
- A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancerBritish Journal of Cancer, 2006
- Cremophor ELEuropean Journal of Cancer, 2001